Tachyon Therapeutics develops novel, selective compounds to improve the treatment of cancer.
Business Model:
Revenue: $0
Employees: 1-10
Address:
City: San Francisco
State: California
Zip:
Country: United States
Tachyon Therapeutics develops novel, selective compounds to improve the treatment of cancer. The company is currently conducting Phase 1 clinical research in patients with advanced cancer to assess the safety, pharmacokinetics, and anti-tumor effectiveness of TACH101. The programs will be advanced in a timely, innovative, high-quality, and scientifically sound manner.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 3/2023 | Series A | $0 |
Khosla Ventures Red Tree Venture Capital Veblen Ventures Khosla Ventures Red Tree Venture Capital Veblen Ventures Khosla Ventures Red Tree Venture Capital Veblen Ventures Khosla Ventures Red Tree Venture Capital Veblen Ventures |
3/2023 | Grant | 1 | $7.1M |
California Institute for Regenerative Medicine California Institute for Regenerative Medicine California Institute for Regenerative Medicine |
1/2020 | Seed Round | - | 3/2023 | Series A | 3 | $11.6M |
Khosla Ventures Red Tree Venture Capital Veblen Ventures Khosla Ventures Red Tree Venture Capital Veblen Ventures |
1/2020 | Seed Round | - |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|